2016
DOI: 10.1016/j.xphs.2016.02.029
|View full text |Cite
|
Sign up to set email alerts
|

Residual Host Cell Protein Promotes Polysorbate 20 Degradation in a Sulfatase Drug Product Leading to Free Fatty Acid Particles

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

3
107
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 140 publications
(110 citation statements)
references
References 31 publications
3
107
0
Order By: Relevance
“…Given the structural similarities between polysorbates and triglycerides, it is hypothesized that LPL may enzymatically degrade polysorbates and consequently negatively impact mAb stability. A similar mechanism has recently been proposed to be associated with the degradation of PS-20 in a non-mAb product formulation by putative phospholipase B-like 2 (PLBL2) (Dixit et al, 2016). PLBL2 is an HCP impurity that was previously identified to have variable expression during extended culture (Valente at al., 2015).…”
Section: Introductionmentioning
confidence: 70%
See 1 more Smart Citation
“…Given the structural similarities between polysorbates and triglycerides, it is hypothesized that LPL may enzymatically degrade polysorbates and consequently negatively impact mAb stability. A similar mechanism has recently been proposed to be associated with the degradation of PS-20 in a non-mAb product formulation by putative phospholipase B-like 2 (PLBL2) (Dixit et al, 2016). PLBL2 is an HCP impurity that was previously identified to have variable expression during extended culture (Valente at al., 2015).…”
Section: Introductionmentioning
confidence: 70%
“…They are thought to stabilize high-concentration mAb solutions by competing with mAbs for surface adsorption (Mahler et al, 2009) or binding to the product molecules (Lee et al, 2011). Several different routes of polysorbate degradation in formulations have previously been identified (Dixit et al, 2016; Ha et al, 2002; Khossravi et al, 2002; Kishore et al, 2011; Hall et al, 2016), with degradation leading to accelerated product degradation due to increased aggregation (Khossravi et al, 2002) or oxidation due to peroxide formation (Ha et al, 2002). …”
Section: Introductionmentioning
confidence: 99%
“…Due to higher cell concentration and longer culture duration, the host cell proteins (HCPs) that are secreted from viable cells and released from dead cells accumulate extracellularly at a much higher level in fed‐batch cultures than they do in batch cultures, thereby potentially impairing product quality (Aboulaich et al, ; Huang et al, ). In addition, certain HCPs in culture supernatants may escape an entire purification process and remain in the final drug substances at levels that affect product stability (Dixit et al, ). Therefore, it is important to characterize the HCPs in culture supernatants to ensure optimal product quality and stability.…”
Section: Introductionmentioning
confidence: 99%
“…In particular, proteases789 and glycosidases1011 that accumulate in culture medium negatively affect the quality of mAbs in recombinant CHO (rCHO) cell cultures. In addition, although the concentrations of HCPs in cell culture harvests are reduced to acceptable levels after a series of purification steps, certain HCPs escape an entire purification process and remain in the final mAb drug substance at levels that affect product quality and stability1213. Therefore, it is paramount to characterize and quantify HCPs in fed-batch cultures to ensure an optimal mAb quality and perform targeted removal of HCPs during the purification steps.…”
mentioning
confidence: 99%